Entry
Symbol
IL2, IL-2, TCGF, lymphokine
Name
KO
Organism
Pathway
hsa04060 Cytokine-cytokine receptor interaction
hsa04061 Viral protein interaction with cytokine and cytokine receptor
hsa04625 C-type lectin receptor signaling pathway
hsa04658 Th1 and Th2 cell differentiation
hsa04660 T cell receptor signaling pathway
hsa04672 Intestinal immune network for IgA production
hsa05166 Human T-cell leukemia virus 1 infection
Network
nt06160 Human T-cell leukemia virus 1 (HTLV-1)
nt06162 Hepatitis B virus (HBV)
nt06164 Kaposi sarcoma-associated herpesvirus (KSHV)
nt06165 Epstein-Barr virus (EBV)
nt06219 JAK-STAT signaling (cancer)
nt06263 Hepatocellular carcinoma
nt06266 Non-small cell lung cancer
nt06276 Chronic myeloid leukemia
nt06518 JAK-STAT signaling
Element
N00053 Cytokine-Jak-STAT signaling pathway
N00491 HTLV-1 p12 to Jak-STAT signaling pathway
N01554 IL2 family to Jak-STAT signaling pathway
Disease
H00084 Graft-versus-host disease
H00408 Type 1 diabetes mellitus
Drug target
Brite
KEGG Orthology (KO) [BR:hsa00001 ]
09130 Environmental Information Processing
09132 Signal transduction
04630 JAK-STAT signaling pathway
3558 (IL2)
04151 PI3K-Akt signaling pathway
3558 (IL2)
09133 Signaling molecules and interaction
04060 Cytokine-cytokine receptor interaction
3558 (IL2)
04061 Viral protein interaction with cytokine and cytokine receptor
3558 (IL2)
09150 Organismal Systems
09151 Immune system
04625 C-type lectin receptor signaling pathway
3558 (IL2)
04660 T cell receptor signaling pathway
3558 (IL2)
04658 Th1 and Th2 cell differentiation
3558 (IL2)
04659 Th17 cell differentiation
3558 (IL2)
04672 Intestinal immune network for IgA production
3558 (IL2)
09160 Human Diseases
09161 Cancer: overview
05200 Pathways in cancer
3558 (IL2)
09172 Infectious disease: viral
05166 Human T-cell leukemia virus 1 infection
3558 (IL2)
05171 Coronavirus disease - COVID-19
3558 (IL2)
05162 Measles
3558 (IL2)
09171 Infectious disease: bacterial
05135 Yersinia infection
3558 (IL2)
09174 Infectious disease: parasitic
05142 Chagas disease
3558 (IL2)
09163 Immune disease
05320 Autoimmune thyroid disease
3558 (IL2)
05321 Inflammatory bowel disease
3558 (IL2)
05330 Allograft rejection
3558 (IL2)
05332 Graft-versus-host disease
3558 (IL2)
09167 Endocrine and metabolic disease
04940 Type I diabetes mellitus
3558 (IL2)
09180 Brite Hierarchies
09183 Protein families: signaling and cellular processes
04052 Cytokines and neuropeptides [BR:hsa04052 ]
3558 (IL2)
00536 Glycosaminoglycan binding proteins [BR:hsa00536 ]
3558 (IL2)
Cytokines and neuropeptides [BR:hsa04052 ]
Cytokines
Interleukins
3558 (IL2)
Glycosaminoglycan binding proteins [BR:hsa00536 ]
Heparan sulfate / Heparin
Cytokines
3558 (IL2)
BRITE hierarchy
SSDB
Ortholog Paralog Gene cluster GFIT
Motif
Motif
Other DBs
Structure
PDB
LinkDB
All DBs
Position
4:complement(122451470..122456725)
Genome browser
AA seq
153 aa AA seq DB search
MYRMQLLSCIALSLALVTNSAPTSSSTKKTQLQLEHLLLDLQMILNGINNYKNPKLTRML
TFKFYMPKKATELKHLQCLEEELKPLEEVLNLAQSKNFHLRPRDLISNINVIVLELKGSE
TTFMCEYADETATIVEFLNRWITFCQSIISTLT
NT seq
462 nt NT seq +upstream nt +downstream nt
atgtacaggatgcaactcctgtcttgcattgcactaagtcttgcacttgtcacaaacagt
gcacctacttcaagttctacaaagaaaacacagctacaactggagcatttactgctggat
ttacagatgattttgaatggaattaataattacaagaatcccaaactcaccaggatgctc
acatttaagttttacatgcccaagaaggccacagaactgaaacatcttcagtgtctagaa
gaagaactcaaacctctggaggaagtgctaaatttagctcaaagcaaaaactttcactta
agacccagggacttaatcagcaatatcaacgtaatagttctggaactaaagggatctgaa
acaacattcatgtgtgaatatgctgatgagacagcaaccattgtagaatttctgaacaga
tggattaccttttgtcaaagcatcatctcaacactgacttga